Visualizing cost-effectiveness analysis.
Mark
David H
DH
D003362:Cost-Benefit Analysis; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D008962:Models, Theoretical; D027383:Papillomaviridae / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000175:diagnosis; D014412:Tumor Virus Infections / Q000175:diagnosis; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D014626:Vaginal Smears / Q000191:economics
D004279:DNA, Viral